The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.50
Bid: 47.15
Ask: 47.55
Change: 0.05 (0.11%)
Spread: 0.40 (0.848%)
Open: 48.50
High: 48.50
Low: 47.05
Prev. Close: 47.45
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of bondholder meetings

25 Oct 2018 14:10

RNS Number : 2137F
Old Mutual Limited
25 October 2018
 

Old Mutual Limited

Incorporated in the Republic of South Africa

Registration number: 2017/235138/06

ISIN: ZAE000255360

LEI: 213800MON84ZWWPQCN47

JSE Share Code: OMU

NSX Share Code: OMM

("Old Mutual")

 

 

Ref 72_18

25 October 2018

NOT FOR DISTRIBUTION INTO ANY JURISDICTION OR TO ANY PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

OUTCOMES OF BONDHOLDER MEETINGS

 

OLD MUTUAL SUBSIDIARY OLD MUTUAL PLC ANNOUNCES THE CONVENING OF ADJOURNED NOTEHOLDER MEETINGS AND THE OUTCOME OF SEPARATE NOTEHOLDER MEETINGS OF ITS OUTSTANDING £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 TO APPROVE BY WAY OF EXTRAORDINARY RESOLUTION CERTAIN MODIFICATIONS TO THE TERMS AND CONDITIONS OF THE RELEVANT SERIES AND THE RELEVANT TRUST DEED CONSTITUTING THE RELEVANT SERIES

 

The body of the Old Mutual plc announcement (as published on the London Stock Exchange website) is set out below.

----------------------------------------------------------------------------------------------------------------------------------

Old Mutual plc (the "Company") announces THE CONVENING OF ADJOURNED NOTEHOLDER MEETINGS AND THE OUTCOME of SEPARATE NOTEHOLDER MEETINGs of its outstanding £500,000,000 8 PER CENT. SUBORDINATED NOTES DUE 3 JUNE 2021 (the "2021 Securities") AND ITS OUTSTANDING £450,000,000 7.875 PER CENT. SUBORDINATED NOTES DUE 3 NOVEMBER 2025 (the "2025 Securities" and, together with the 2021 Securities, the "Securities", and each a "Series") to approve by way of extraordinary resolution certain modifications to the terms and conditions of the relevant series and the relevant trust deed constituting the relevant series

 

On 26 September 2018, the Company announced its separate invitations to holders of its 2021 Securities (the "2021 Securityholders") and to holders of its 2025 Securities (the "2025 Securityholders" and, together with the 2021 Securityholders, the "Securityholders") in each case to approve, by way of Extraordinary Resolution, the relevant Proposal, comprising certain modifications to the terms and conditions of the relevant Series (in respect of such Series, the "Conditions") and the trust deed constituting the relevant Series as further detailed in the Consent Solicitation Memorandum dated 26 September 2018 (the "Consent Solicitation Memorandum"), subject, in each case, to the terms and conditions set out in the Consent Solicitation Memorandum as amended by this announcement (see below). Copies of the Consent Solicitation Memorandum are available from the Tabulation Agent as set out below. Capitalised terms used in this announcement but not defined have the meanings given to them in the Consent Solicitation Memorandum.

Results of the Proposals

The Meetings to consider the Proposals were held earlier today, and NOTICE IS HEREBY GIVEN to Securityholders that:

(a) the Meeting in relation to the 2021 Securities was not quorate and has therefore been adjourned until 10.00 a.m. (London time) on 12 November 2018 to be held at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ (the "2021 Securities Adjourned Meeting");

(b) the Meeting in relation to the 2025 Securities was not quorate and has therefore been adjourned until 10.15 a.m. (London time) on 12 November 2018 to be held at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ (the "2025 Securities Adjourned Meeting", and, together with the 2021 Securities Adjourned Meeting, the "Adjourned Meetings", and each an "Adjourned Meeting"); and

(c) pursuant to the terms of the Consent Solicitation Memorandum, the Company hereby announces that the Consent Deadline in respect of the Securities will be extended to 4.00 p.m. (London time) on 7 November 2018 to provide Securityholders with further time to deliver, or arrange to have delivered on their behalf, a valid Solicitation Instruction in favour of the relevant Extraordinary Resolution in order to be eligible to receive the Consent Fee. As such, Securityholders may continue to submit Solicitation Instructions up to 4.00 p.m. (London time) on 7 November 2018. Securityholders who deliver, or arrange to have delivered on their behalf, a valid Solicitation Instruction in favour of the relevant Extraordinary Resolution which are received by the Tabulation Agent by the Consent Deadline will be eligible to receive the Consent Fee.

Notices convening the Adjourned Meetings shall be given to Securityholders in accordance with the relevant Trust Deed on the date of this announcement.

Solicitation Instructions previously submitted in accordance with the procedures set out in the Consent Solicitation Memorandum and which have not been subsequently validly revoked (in the limited circumstances in which such revocation is permitted) shall remain valid for the relevant Adjourned Meeting and, for avoidance of doubt, no further action is required from Securityholders who previously submitted such Solicitation Instructions. The results of the Adjourned Meetings are expected to be announced as soon as reasonably practicable after the Adjourned Meetings.

Securityholders should refer to the relevant Notice for full details of the procedures in relation to the relevant Adjourned Meeting.

General

Securityholders are advised to check with any bank, securities broker or other intermediary through which they hold their Securities when such intermediary would need to receive instructions from a Securityholder in order for such Securityholder to participate in, or (in the limited circumstances in which revocation is permitted) to validly revoke their instruction to participate in, the Consent Solicitation and/or vote in respect of either or both of the Proposals before the deadlines specified above. The deadlines set by any such intermediary and each Clearing System for the submission and (where permitted) revocation of Solicitation Instructions will be earlier than the relevant deadlines above and in the Consent Solicitation Memorandum.

Unless stated otherwise, announcements in connection with the Consent Solicitation and the Proposals will be made (i) by publication via RNS and (ii) by the delivery of notices to the Clearing Systems for communication to Direct Participants. Such announcements may also be made on the relevant Reuters Insider Screen and by the issue of a press release to a Notifying News Service. Copies of all such announcements, notices and press releases can also be obtained upon request from the Tabulation Agent.

In addition to this announcement, Securityholders are advised to read carefully the Consent Solicitation Memorandum for full details of and information on the procedures for participating in the Consent Solicitation.

Requests for information in relation to the Consent Solicitation and the Proposals should be directed to:

The Solicitation Agent

Merrill Lynch International2 King Edward StreetLondon EC1A 1HQUnited Kingdom

Telephone: +44 20 7996 5420Attention: Liability Management GroupEmail: DG.LM_EMEA@baml.com

 

Requests for information in relation to the submission of a Solicitation Instruction in favour of either Proposal should be directed to:

The Tabulation Agent

Lucid Issuer Services LimitedTankerton Works12 Argyle WalkLondon WC1H 8HAUnited Kingdom

Telephone: + 44 20 7704 0880Attention: Arlind BytyqiEmail: oldmutual@lucid-is.com

DISCLAIMER This announcement must be read in conjunction with the Consent Solicitation Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement.

This announcement and Consent Solicitation Memorandum contain important information which should be read carefully before any decision is made with respect to the Consent Solicitation and the Proposal. If any Securityholder is in any doubt as to the action it should take, it is recommended to seek its own financial and legal advice, including in respect of any tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. Any individual or company whose Securities are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee or intermediary must contact such entity if it wishes to participate in the Consent Solicitation or otherwise vote in respect of either or both of the Proposals. None of the Company, the Solicitation Agent, the Tabulation Agent, the Principal Paying Agent, the Registrar, the Trustee or any of their respective agents, directors, employees, representatives or affiliates makes any representation or recommendation as to whether Securityholders should participate in the Consent Solicitation or otherwise vote in respect of the relevant Proposal. The distribution of this announcement and the Consent Solicitation Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Consent Solicitation Memorandum comes are required by each of the Company, the Solicitation Agent and the Tabulation Agent to inform themselves about, and to observe, any such restrictions.

Nothing in this announcement and/or the Consent Solicitation Memorandum constitutes or contemplates an offer of, an offer to purchase or the solicitation of an offer to purchase or sell any security in the United States or in any other jurisdiction.

 

 

----------------------------------------------------------------------------------------------------------------------------------

 

JSE Sponsor: Merrill Lynch South Africa (Pty) Limited

Namibian Sponsor: PSG Wealth Management (Namibia) (Proprietary) Limited

 

Enquiries

Investor Relations

Patrick Bowes (Interim Head of Investor Relations)

 

T: +44 (0)20 7002 7440

E: patrick.bowes@omg.co.uk

Communications:

Tabby Tsengiwe

 

T: +27 (11) 217 1953

M: +27 (0)60 547 4947

E: ttsengiwe@oldmutual.com

 

Notes to Editors

 

About Old Mutual Limited

 

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key markets segments in 17 countries. Old Mutual's primary operations are in South Africa and the rest of Africa, and it has niche businesses in Latin America and Asia. With over 170 years of heritage across sub-Saharan Africa, we are a crucial part of the communities we serve and broader society on the continent.

 

For further information on Old Mutual, and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFSFITLEFIT
Date   Source Headline
13th Feb 202411:00 amRNSForm 8.3 - Mondi Plc
2nd Jan 20243:00 pmRNSDealings in securities on behalf of Share Trusts
27th Dec 20233:00 pmRNSDealings in securities on behalf of ESIS
21st Dec 20233:00 pmRNSChange of the JSE Equity Sponsor
20th Dec 20233:30 pmRNSDealings in securities on behalf of ESIS
19th Dec 20233:30 pmRNSSecurities dealings on behalf of ESIS
12th Dec 20233:45 pmRNSChange in JSE equity sponsor
5th Dec 20233:45 pmRNSDirectorate Change
5th Dec 20233:00 pmRNSDirector/PDMR Shareholding
30th Nov 202311:00 amRNSDirector/PDMR Shareholding
22nd Nov 20238:00 amRNSOld Mutual Limited Voluntary Operating Update
9th Nov 20233:00 pmRNSDirector/PDMR Shareholding
31st Oct 20233:00 pmRNSDirector/PDMR Shareholding
26th Oct 20234:30 pmRNSOld Mutual Share Repurchase programme
25th Oct 20234:30 pmRNSDealings in securities on behalf of ESIS
20th Oct 20234:00 pmRNSDealings in securities on behalf of ESIS
17th Oct 20232:30 pmRNSDealing in securities on behalf of ESIS
3rd Oct 20239:00 amRNSFinalisation and dividend currency equivalents
27th Sep 20237:00 amRNSUnaudited Interim Results and Dividend Declaration
13th Sep 20237:00 amRNSVoluntary Trading Statement
28th Jul 20237:00 amRNSInvestor update and release of information
30th May 202310:00 amRNSOld Mutual Share Repurchase Programme
30th May 20237:00 amRNSResult of AGM
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
25th May 202311:40 amRNSVoluntary Operating Update
18th May 20231:30 pmRNSForm 8.3 - Mediclinic International plc
11th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
4th May 20231:45 pmRNSForm 8.3 - Mediclinic International plc
27th Apr 20232:00 pmRNSForm 8.3 - Mediclinic International plc
25th Apr 20233:30 pmRNSNotice of AGM and no change statement
24th Apr 202311:00 amRNSDirector/PDMR Shareholding
21st Apr 20231:45 pmRNSForm 8.3 - [Mediclinic International plc]
19th Apr 20234:00 pmRNSDirector/PDMR Shareholding
14th Apr 202311:00 amRNSRelease of Integrated Report & Investor Engagement
13th Apr 202312:30 pmRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSForm 8.3 - [Mediclinic International plc]
6th Apr 20234:40 pmRNSDirector/PDMR Shareholding
6th Apr 20232:45 pmRNSDealings in securities on behalf of ESIS
6th Apr 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Apr 202311:00 amRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20232:00 pmRNSForm 8.3 - [Mediclinic International plc]
4th Apr 20231:00 pmRNSDealings in securities on behalf of ESOP
4th Apr 20239:00 amRNSOML BEE certificate and annual compliance report
31st Mar 20232:30 pmRNSDealings in Securities on behalf of Share Trusts
30th Mar 202312:15 pmRNSForm 8.3 - [Mediclinic International plc]
29th Mar 20232:30 pmRNSDealings in securities on behalf of share trusts
27th Mar 20234:15 pmRNSDealings in securities on behalf of a share trust
24th Mar 20237:00 amRNSNo change statement
22nd Mar 20238:00 amRNSFINALISATION AND DIVIDEND CURRENCY EQUIVALENTS
17th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.